Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 13 04:00PM ET
0.9281
Dollar change
-0.1019
Percentage change
-9.89
%
Index- P/E- EPS (ttm)-2.33 Insider Own5.67% Shs Outstand16.52M Perf Week-5.76%
Market Cap15.33M Forward P/E- EPS next Y-0.82 Insider Trans34.61% Shs Float15.58M Perf Month27.47%
Income-20.99M PEG- EPS next Q-0.34 Inst Own15.66% Short Float4.07% Perf Quarter-81.73%
Sales0.38M P/S40.34 EPS this Y56.08% Inst Trans-0.96% Short Ratio0.58 Perf Half Y-65.11%
Book/sh1.13 P/B0.82 EPS next Y53.67% ROA-47.53% Short Interest0.63M Perf Year-62.35%
Cash/sh0.30 P/C3.09 EPS next 5Y- ROE-90.83% 52W Range0.64 - 6.89 Perf YTD-62.12%
Dividend Est.- P/FCF- EPS past 5Y57.55% ROIC-153.16% 52W High-86.53% Beta0.94
Dividend TTM- Quick Ratio1.12 Sales past 5Y-35.52% Gross Margin-199.20% 52W Low45.97% ATR (14)0.11
Dividend Ex-Date- Current Ratio1.12 EPS Y/Y TTM85.42% Oper. Margin-4483.47% RSI (14)45.77 Volatility7.58% 6.27%
Employees19 Debt/Eq0.34 Sales Y/Y TTM650.00% Profit Margin-5597.87% Recom1.00 Target Price5.50
Option/ShortNo / Yes LT Debt/Eq0.20 EPS Q/Q42.30% Payout- Rel Volume0.32 Prev Close1.03
Sales Surprise-100.00% EPS Surprise-53.12% Sales Q/Q- EarningsMay 02 BMO Avg Volume1.10M Price0.93
SMA207.21% SMA50-9.87% SMA200-63.08% Trades Volume360,652 Change-9.89%
Date Action Analyst Rating Change Price Target Change
May-28-24Initiated Chardan Capital Markets Buy $5
Nov-29-21Initiated JMP Securities Mkt Outperform $1.50
Jan-22-21Initiated Cantor Fitzgerald Overweight $3
Jun-26-20Initiated Alliance Global Partners Buy $2.55
May-05-25 08:00AM
May-02-25 08:00AM
Apr-29-25 01:43PM
Apr-22-25 08:00AM
Apr-07-25 07:00AM
10:00AM Loading…
Apr-01-25 10:00AM
Feb-19-25 04:05PM
Feb-17-25 04:38PM
Feb-10-25 04:05PM
Jan-13-25 07:00AM
Jan-07-25 07:00AM
Jan-03-25 07:58AM
Jan-02-25 09:24AM
07:00AM
Nov-25-24 08:00AM
04:05PM Loading…
Nov-12-24 04:05PM
Oct-10-24 08:00AM
Sep-20-24 04:05PM
Sep-03-24 07:00AM
Aug-12-24 04:30PM
Jun-03-24 07:00AM
May-13-24 04:05PM
Apr-05-24 02:35PM
Mar-27-24 07:00AM
Mar-26-24 07:35PM
Mar-24-24 03:54PM
Feb-26-24 07:45AM
Jan-16-24 08:15AM
Dec-26-23 07:15AM
Dec-05-23 08:00AM
05:20PM Loading…
Nov-27-23 05:20PM
Nov-01-23 08:24AM
Oct-10-23 08:00AM
Oct-02-23 06:45AM
Sep-27-23 04:19PM
Sep-21-23 04:05PM
Aug-14-23 04:15PM
Jun-27-23 08:00AM
Jun-20-23 08:25AM
Jun-12-23 04:15PM
Jun-06-23 08:00AM
May-09-23 04:30PM
Apr-04-23 04:05PM
Mar-31-23 08:10AM
Feb-16-23 04:48PM
Jan-05-23 08:00AM
Dec-09-22 04:05PM
Dec-06-22 11:27PM
04:01PM
08:00AM
Dec-05-22 08:00AM
Dec-02-22 04:30PM
Nov-03-22 08:00AM
Oct-27-22 06:40PM
Sep-30-22 11:48AM
Sep-27-22 04:30PM
04:10PM
Sep-21-22 08:30AM
Aug-16-22 09:00AM
May-18-22 08:00AM
May-16-22 10:25AM
May-12-22 04:05PM
May-09-22 08:00AM
May-05-22 04:30PM
May-02-22 08:00AM
Mar-11-22 08:00AM
Feb-14-22 04:05PM
Feb-07-22 04:30PM
Jan-26-22 11:21AM
09:00AM
Jan-04-22 04:30PM
Dec-22-21 09:25AM
Dec-21-21 09:20AM
Dec-10-21 08:30AM
Nov-30-21 11:57AM
08:00AM
Nov-29-21 08:45AM
Nov-17-21 04:30PM
Nov-15-21 04:05PM
01:00PM
Nov-08-21 04:30PM
Nov-03-21 04:47PM
Oct-26-21 08:35AM
Oct-02-21 07:31AM
Sep-27-21 07:30AM
Sep-20-21 04:30PM
07:30AM
Sep-07-21 04:30PM
Aug-26-21 07:00AM
Aug-25-21 11:16AM
07:30AM
Jul-15-21 05:10PM
Jul-09-21 06:10AM
Jul-08-21 04:15PM
Jun-18-21 09:13PM
Jun-09-21 04:30PM
May-19-21 04:30PM
May-17-21 07:00AM
06:15AM
May-10-21 08:15AM
iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets. The company was founded on April 17, 2008 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Duran FelipeChief Financial OfficerJan 10 '25Buy2.729,19125,00011,139Jan 13 04:34 PM
Brenner MartinSee RemarksJan 10 '25Buy2.729,19125,00018,316Jan 13 04:34 PM
Banjak MarcChief Legal OfficerJan 10 '25Buy2.729,19125,00011,066Jan 13 04:33 PM
Arkowitz DavidDirectorJan 10 '25Buy2.7218,38249,99918,382Jan 13 04:32 PM
Clark William DDirectorJan 10 '25Buy2.721,8384,9991,838Jan 13 04:31 PM
Parada Antonio Bernardino GuimDirectorJan 10 '25Buy2.72183,823499,999183,823Jan 13 04:30 PM
Sender GaryDirectorJan 10 '25Buy2.729,19125,0009,191Jan 13 04:30 PM